Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
CALIFORNIA BANCORP ANNOUNCES FIRST CASH DIVIDEND
-
SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management
-
4DMT to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Gabelli Launches Keeley Dividend ETF (KDVD)
-
Brazil Potash Achieved Major 2025 Milestones, Positions for Construction Advancement in 2026
-
How Fenstermaker Uses Handheld Lidar to Map Schools for 911 Safety and Response
-
Westwood Holdings Group, Inc. Recognized in Pensions & Investments’ Best Places to Work in Money Management
-
ASML reports transactions under its current share buyback program
-
Roche’s Columvi combination shows sustained survival benefit at three-year follow up of pivotal phase III STARGLO study
-
Total Return Securities Fund Announces Expiration of Rights Offering
-
Transcontinental Inc. enters into Agreement to Sell its Packaging Business
-
Bang & Olufsen A/S - Transactions in connection with share buyback programme to hedge the company’s share-based incentive programmes
-
Zelluna ASA: New share capital registered
-
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026
-
ContextLogic to Acquire US Salt from Emerald Lake in $907.5 Million Transaction, Creating New Business Ownership Platform in Partnership with Abrams Capital and BC Partners Credit
-
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
-
Stock Yards Bancorp Announces Promotion of William Otten to Chief Credit Officer of the Company as William Dishman Sets Retirement Date
-
Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
-
Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at
-
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
-
Onex Completes Final Realization of Ryan Specialty, Delivering Strong Investing Results
-
Digi Power X Appoints Chief Technology Officer
-
Gemini to Participate in Goldman Sachs 2025 Financial Services Conference
-
Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy
-
Gray Announces Private Placement of $250 Million of Additional 9.625% Senior Secured Second Lien Notes due 2032
-
Dragonfly Energy Expands Marine OEM Footprint with World’s Largest Power Catamaran Manufacturer, World Cat
-
BiomX Announces Discontinuation of Phase 2b BX004 Trial Following Internal Review
-
Bitcoin Munari Advances to Round 4 at $0.50 as ETF Accumulation Models Dominate Market Debate
-
1 billion financing empowers! EngineAI T800 comes out in a big way, accelerating industrialization process
-
REKT Announces Launch of the First Meme Token That Rewards Losing Trades
-
Drone Nerds Expands Technology Portfolio with New Creality Partnership
-
Kraig Biocraft Laboratories Secures Usage Rights to Strategic Government-Owned Mulberry Gardens to Support Major Spider Silk Production Expansion
-
Asante Gold Announces Intention to Dual List on ASX
-
Mercury Showcases Expanding Portfolio of Electronic Warfare Capabilities at AOC 2025
-
Xali Gold Files Technical Report on the Pico Machay Gold Project in Peru
-
Ocular Therapeutix™ Announces Plans to Accelerate NDA Submission Timeline for AXPAXLI™ in Wet AMD
-
Tecnoglass to Attend the Raymond James 2025 TMT & Consumer Conference
-
Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader, in Patients with Moderate to Severe Atopic Dermatitis
-
Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia
-
Copper Road signs Four Separate Option Agreements Consolidating the Ben Nevis Volcanic Complex into a Single Claim Group
-
Gogo makes a strategic investment in Farcast to support new cutting-edge user terminal technology to enhance inflight connectivity for business, military, and government aviation
-
Gaming and Leisure Properties Expands Board of Directors With Appointment of Michael Borofsky
-
Kamada Announces Discontinuation of its Phase 3 Inhaled AAT Clinical Trial; Reiterates 2025 Full-Year Guidance and Projects Double-Digit Growth in Revenues and Profitability in 2026
-
14 G/T Au Within 47m of Gold-Bearing Skarn from 26m Depth in 300m Step-Out at Birch Cu-Au Project
-
Montara Therapeutics Announces Development Candidate for First BrainOnly™-Enabled Program in TSC-Related Epilepsy and Appoints Chief Business Officer
-
Cardiff Oncology to Present at Sidoti’s Year-End Virtual Investor Conference
-
New Crypto Coin Mutuum Finance (MUTM) Phase 6 Is 96% Sold Out With $19.2M Already Raised
-
Aurora Mobile’s EngageLab Launches AI-Powered Customer Service Platform LiveDesk, Revolutionizing Enterprise Customer Experience
-
EUDA Plans to Integrate QB Utility Token into Its Healthcare Ecosystem
-
Vaxcyte Doses First Participants in the OPUS Phase 3, Noninferiority Trial Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
